Rebecca I Hartman, MD, MPH, FAAD
SESSIONS
F025 The Changing Landscape of Early-stage Melanoma Management
Mar 8, 2025
•
9:00 AM - 12:00 AM
•
W314B
U047 Melanoma in Special Populations
Mar 8, 2025
•
4:30 PM - 12:00 AM
•
W304A
U057 When to Put Down the Scalpel: Non-surgical Therapies for Skin Cancer
Mar 9, 2025
•
8:00 AM - 12:00 AM
•
W202C
HANDOUTS
Login to view handouts
DISCLOSURES
Almirall – Consultant (1099 relationship)(Fees); Evereden – Advisory Board(Stock), Consultant(Fees); Lumo Imaging – Advisory Board(No Compensation Received); Med Learning Group – Speaker/Faculty Education(Fees); MJH Life Sciences – Consultant (1099 relationship)(Fees); Moderna Therapeutics – Speaker(Fees); Prime Education – Speaker/Faculty Education(Fees); Veriskin – Investigator(Grants/Research Funding); Vita Imaging – Investigator(Grants/Research Funding); Zura Bio – Data Safety Monitoring Board(Fees);